About Wytech Pharmaceuticals Private Limited
Data last updated:
Wytech Pharmaceuticals Private Limited is a private limited company based in Chandigarh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 09 November 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24233CH2015PTC035814. Its GSTIN is 04AABCW7264J1Z4 (Chandigarh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Satbir Singh and Hemdeep Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Office No.186 – 188 Sector 17 – C, Chandigarh, India – 160017.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.52 Cr, a decline of 8% compared to the previous year. For the same year it recorded a net profit of ₹3.28 Lakh (net margin 2.1%) and EBITDA of ₹13.65 Lakh (EBITDA margin 9%). Revenue has declined at a compounded annual rate (CAGR) of 6% over three years and 1% over five years.
The company is associated with 1 brand: Wytech Pharmaceuticals.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website wytechpharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressOffice No.186 – 188 Sector 17 – C, Chandigarh, India – 160017
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Wytech Pharmaceuticals Private Limited
The main business activity of Wytech Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Wytech Pharmaceuticals Private Limited FY 2025 filings available
Wytech Pharmaceuticals Private Limited reported revenue of ₹1.52 Cr (down 8% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Wytech Pharmaceuticals Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 1% over five years, including a 8% fall in the latest year. EBITDA rose 75% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Wytech Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹13.65 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹3.28 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Wytech Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 9% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 2.1% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Wytech Pharmaceuticals are in the company report.
Financial statements from FY 2016
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Wytech Pharmaceuticals Private Limited
Wytech Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Lalith Pharma-Marketing Private Limited | ₹1.53 Cr (FY 2025) | •••• | •••• | 20.0% | •••• | Banagalore, Karnataka, India |
| Shree Vishwamitra Ayurved Pharmaceuticals Private Limited | ₹1.53 Cr (FY 2025) | •••• | •••• | 10.0% | •••• | Ahmedabad, Gujarat, India |
| Afd Laboratories Private Limited | ₹1.53 Cr (FY 2023) | •••• | •••• | 3.0% | •••• | Mumbai, Maharashtra, India |
| Skydew Pharmaceutical Private Limited | ₹1.52 Cr (FY 2025) | •••• | •••• | 283.0% | •••• | Lucknow, Uttar Pradesh, India |
| Cure Quick Pharma Private Limited | ₹1.52 Cr (FY 2021) | •••• | •••• | -65.0% | •••• | New Delhi, Delhi, India |
| Wytech Pharmaceuticals Private Limited this company | ₹1.52 Cr (FY 2025) | •••• | •••• | -8.0% | •••• | Chandigarh, India |
| Sahana Pharmaceuticals Private Limited | ₹1.52 Cr (FY 2025) | •••• | •••• | 41.0% | •••• | Nagercoil, Tamil Nadu, India |
| Aaryan Biocare Products Private Limited | ₹1.52 Cr (FY 2025) | •••• | •••• | -13.0% | •••• | Pune, Maharashtra, India |
| Bharat Remedies Pvt Ltd | ₹1.52 Cr (FY 2024) | •••• | •••• | -23.0% | •••• | Punjab, India |
| Inizia Healthcare Private Limited | ₹1.52 Cr (FY 2017) | •••• | •••• | •••• | Ahmedabad, Gujarat, India | |
| Zoptus Pharmaceuticals Private Limited | ₹1.52 Cr (FY 2025) | •••• | •••• | 15.0% | •••• | Varanasi, Uttar Pradesh, India |
Peers are the five companies nearest above and the five nearest below Wytech Pharmaceuticals by revenue in the Pharma industry (Formulations, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Wytech Pharmaceuticals Private Limited
Wytech Pharmaceuticals Private Limited is audited by VIKAS SANJIV & ASSOCIATES for the financial year 2021.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| VIKAS SANJIV & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Wytech Pharmaceuticals Private Limited
Wytech Pharmaceuticals has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Satbir Singh | Director | 09 Nov 2015 | 10 Years 11 Months | Current |
| Hemdeep Singh | Director | 09 Nov 2015 | 10 Years 11 Months | Current |
| Manmohan Singh Saggu | Director | 22 Dec 2022 | 3 Years 9 Months | Current |
Ownership and Shareholding of Wytech Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Wytech Pharmaceuticals Private Limited
Wytech Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Associated Brands with Wytech Pharmaceuticals Private Limited
Wytech Pharmaceuticals operates one associated brand: Wytech Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical manufacturing with a focus on Cardiology and CNS therapies in India. | wytechpharma.com |
Employees and EPFO Compliance at Wytech Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Wytech Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Wytech Pharmaceuticals Private Limited
Wytech Pharmaceuticals Private Limited has 5 board changes on record since 2015: 4 appointments and 1 cessation. The latest: Manmohan Singh Saggu was appointed as Director on 22 Dec 2022.
Credit Ratings, Litigation & Regulatory Alerts for Wytech Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Wytech Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Wytech Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Wytech Pharmaceuticals Private Limited
Wytech Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 04AABCW7264J1Z4 | Chandigarh | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Wytech Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Wytech Pharmaceuticals Private Limited
Wytech Pharmaceuticals is an active private limited company based in Chandigarh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 09 November 2015 (11+ years old) and is registered under CIN U24233CH2015PTC035814.
Wytech Pharmaceuticals reported revenue of ₹1.52 Cr for FY 2025 (down 8% YoY).
Wytech Pharmaceuticals has 3 current directors:
- Satbir Singh - Director
- Hemdeep Singh - Director
- Manmohan Singh Saggu - Director
Wytech Pharmaceuticals reported a net profit of ₹3.28 Lakh (net margin 2.1%) and EBITDA of ₹13.65 Lakh (EBITDA margin 9%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Wytech Pharmaceuticals is 6% over three years and -1% over five years. In the latest year (FY 2025) revenue fell 8%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Wytech Pharmaceuticals is 04AABCW7264J1Z4, registered in Chandigarh.
The CIN (Corporate Identification Number) of Wytech Pharmaceuticals is U24233CH2015PTC035814. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Wytech Pharmaceuticals was incorporated on 09 November 2015, making it 11+ years old. It is registered with the Registrar of Companies, Chandigarh.
The peers of Wytech Pharmaceuticals by revenue are Lalith Pharma-Marketing Private Limited, Shree Vishwamitra Ayurved Pharmaceuticals Private Limited, Afd Laboratories Private Limited, Skydew Pharmaceutical Private Limited, Cure Quick Pharma Private Limited and 5 more, all in the Pharma industry (Formulations, Pharmaceuticals).
Manmohan Singh Saggu was appointed as Director on 22 Dec 2022. Sudershan Kumar Arora ceased to be Director on 24 Feb 2020. Sudershan Kumar Arora was appointed as Director on 14 Nov 2016. Wytech Pharmaceuticals has 5 board changes on record in total.
Wytech Pharmaceuticals can be reached through the website wytechpharma.com. Its registered office is in Chandigarh, India.